Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy
Clinical trial NCT03069703 · COMPLETED
Trial details
- NCT number
- NCT03069703
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-05
- Primary completion
- 2020-11-24
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.